MedPath
FDA Approval

Pyrimethamine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
DR.REDDYS LABORATORIES INC
DUNS: 802315887
Effective Date
March 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pyrimethamine(25 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Cerovene, Inc.

790387927

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Cerovene, Inc.

DR.REDDYS LABORATORIES INC

Cerovene, Inc.

790387927

Nutra-Med Packaging, Inc.

DR.REDDYS LABORATORIES INC

Cerovene, Inc.

022004902

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pyrimethamine

Product Details

NDC Product Code
43598-672
Application Number
ANDA207127
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 20, 2023
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
Code: Z3614QOX8WClass: ACTIBQuantity: 25 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath